ilc-dover-news

1. ILC Dover Unveils Sentinel XT™ Horizon For Innovative Respiratory Protection With Unmatched Comfort & Safety 1/14/2025

   ILC Dover (“ILC Dover” or the “Company”), an Ingersoll Rand Business and world leader in innovative protective solutions, announced the launch of Sentinel XT™ Horizon. This latest addition to the Sentinel XT™ line of Powered Air-Purifying Respirators (PAPRs) sets a new benchmark in respiratory protection, combining exceptional safety features with unparalleled ease of use.

2. Ingersoll Rand Closes On ILC Dover and Announces Acquisition Of Three Additional Companies 6/4/2024

   Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and industrial solutions, has closed on the previously announced acquisition of ILC Dover (“ILC”) and has acquired Complete Air and Power Solutions (“CAPS”), Del PD Pumps & Gear Pvt Ltd. (“Del Pumps”), and Fruvac Ltd. (“Fruitland Manufacturing”) for a combined purchase price of approximately $150 million.

3. ILC Dover Secures North Carolina Facility To Expand Dry Repack Capabilities And Build Out cGMP Raw Materials Portfolio 1/19/2023

   ILC Dover LP, specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, has opened a new facility in Lillington, North Carolina to offer pre-filled trusted-weight cGMP raw materials for the growing biomanufacturing market. As a solutions provider for the expanding life sciences industry, ILC Dover continues to meet market demands by developing comprehensive solutions customized to customers' unique needs and end applications.

4. ILC Dover Announces New Multi-Compendial Water For Injection Solutions For Biopharma And Cell & Gene Therapy Market 8/1/2022

   ILC Dover, specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, announced the launch of Water for Injection (WFI) for the biotherapeutics market.

5. Solving API Manufacturing Challenges With Flexible Containment Webinar Announced for June 21 6/7/2022

   Are you concerned about operational safety and efficiency during API manufacturing? This webinar discusses some of the common challenges faced in handling powders during HAPI/API manufacturing. Key strategies to mitigate risks associated with these issues will be shared including how flexible containment solutions can optimize powder handling during chemical synthesis.

6. ILC Dover Plans To Build New Manufacturing Facility In Poland To Meet Biopharma Industry Needs 5/9/2022

   ILC Dover LP, specializing in innovative single-use and chemical workflow solutions for biotherapeutics and pharmaceutical processing, announced plans to break ground on a new 90,000 sq ft manufacturing site located in Gliwice, Poland in response to continued strong growth within its life sciences business. The state-of-the-art facility equipped with 20,000 sq ft of ISO Class 7 cleanroom capability will manufacture initially single-use powder bags, single-use liquid bags, and single-use fluid transfer assemblies. The new site will provide redundant supply capabilities, reduce the lead times for its European and Asian customers and manufacturing will be consistent with the Company’s global quality system.

7. ILC Dover Announces Single-Use Bags Ideal For Biopharma And Cell/Gene Therapy Drug Manufacturers 3/29/2022

   ILC Dover LP (“ILC Dover” or the “Company”), specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, announced its launch of liquid single-use bioprocessing bags, representing the first of many new products for handling and supply of sterile liquids for the biotherapeutics market.

8. ILC Dover Announces Acquisition Of KSE Scientific To Assist Biopharma, Med Device And Cell & Gene Markets 12/16/2021

   ILC Dover, Inc., a leading designer and manufacturer of high-performance materials for life critical and primarily life sciences-based applications, today announced the acquisition of KSE Scientific (“KSE”), a sterile solutions manufacturer which specializes in the production of Water for Injection (WFI) and related media and buffer solutions for biopharma, cell & gene therapy, tissue banking and medical device end-markets.

9. ILC Dover Announces April 13^th Webinar For Recently Developed Aseptic Isolator System 4/7/2021

   With the development of ILC Dover’s new Aseptic Isolator system new opportunities have opened up for many organizations who were previously able to conduct fill finish activities due to facility restraints or expensive closed barrier systems.

10. ILC Dover Expands Containment Technologies With Acquisition Of UK-Based Solo Containment 9/9/2020

    ILC Dover, Inc. (“ILC Dover” or the “Company”), a world leader in the design and production of single-use flexible solutions for pharmaceutical and biopharmaceutical manufacturing, today announced the acquisition of Solo Containment, Ltd. (“Solo”), a specialist manufacturer of flexible film isolators based in the United Kingdom. The acquisition will grow ILC Dover’s global pharmaceutical and biopharmaceutical business, expanding its solutions for high containment and powder transfer to include aseptic flexible isolators, among others.